Regnum Corp.

Share · US75915R1068 (OTC)

Overview

No Price

Closing Price OTC 04.11.2025: 0,0001 USD

04.11.2025 21:00

Current Prices from Regnum Corp.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
UTC	RGMP	USD	04.11.2025 21:00	0,0001 USD	0,00 USD

Company Profile for Regnum Corp. Share

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.

Get up to date insights from finAgent about Regnum Corp.

Company Data

Name Regnum Corp.

Company Regnum Corp.

Primary Exchange

UTC

ISIN US75915R1068

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Robert J. Stubblefield

Country United States of America

Currency USD

Employees 0,0 T

Address 600 Third Avenue, 10016 New York City

IPO Date 2019-05-29

Ticker Symbols

Name	Symbol
Over The Counter	RGMP

More Shares

Investors who hold Regnum Corp. also have the following shares in their portfolio:

BLACKROCK LONG-TERM MUNICIPAL ADVANTAGE TRUST BLACKROCK LONG-TERM MUNICIPAL ADVANTAGE TRUST OF BENEFICIAL INTEREST Fund

Reales US-BIP Economic indicators

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog